DCTH earnings date and last-quarter result: last quarter beat, P/E 783.12. Updated 2026-07-23.
Delcath Systems (DCTH) Research Hub
Delcath Systems (DCTH) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 14.51 USD (+0.62%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 783.12, market cap 0.44B. This hub links to the full technical, earnings and options research available for DCTH.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 14.51 USD (+0.62%) |
| 52-week range | 11.42 USD – 17.42 USD |
| Trend regime | Range |
| 14-day RSI | 38.7 (Bearish) |
| Trailing P/E | 783.12 |
| Market cap | 0.44B |
| Dividend yield | 0.00% |
Available research for DCTH
Covered Call on DCTH: how it works, illustrative setup around the real 14.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DCTH: how it works, illustrative setup around the real 14.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DCTH: how it works, illustrative setup around the real 14.51 USD price, max profit/loss, breakeven and when to use it. Educational.
DCTH technical analysis: range, last 14.51 USD, RSI 38.7, 52w range 11.42 USD–17.42 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is DCTH in?
Delcath Systems (DCTH) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is DCTH in an uptrend or downtrend?
As of 2026-10-26, DCTH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DCTH's trailing P/E ratio?
DCTH's trailing P/E is 783.12, with a market cap of 0.44B. See the earnings research page for full valuation detail.